Rocket Pharmaceuticals Inc (NASDAQ: RCKT) kicked off on Monday, up 9.29% from the previous trading day, before settling in for the closing price of $3.23. Over the past 52 weeks, RCKT has traded in a range of $2.19-$13.35.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -11.60%. While this was happening, its average annual earnings per share was recorded 24.90%. With a float of $99.61 million, this company’s outstanding shares have now reached $108.21 million.
Rocket Pharmaceuticals Inc (RCKT) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Rocket Pharmaceuticals Inc is 7.95%, while institutional ownership is 86.14%. The most recent insider transaction that took place on Nov 18 ’25, was worth 7,592. In this transaction an insider of this company sold 2,545 shares at a rate of $2.98, taking the stock ownership to the 299,064 shares. Before that another transaction happened on Nov 18 ’25, when Company’s CEO sold 6,276 for $2.98, making the entire transaction worth $18,721. This insider now owns 778,296 shares in total.
Rocket Pharmaceuticals Inc (RCKT) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.62 earnings per share (EPS), higher than consensus estimate (set at -0.72) by 0.1. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.44 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 24.90% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 21.89% during the next five years compared to -11.60% drop over the previous five years of trading.
Rocket Pharmaceuticals Inc (NASDAQ: RCKT) Trading Performance Indicators
Take a look at Rocket Pharmaceuticals Inc’s (RCKT) current performance indicators. Last quarter, stock had a quick ratio of 7.30.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.25, a number that is poised to hit -0.43 in the next quarter and is forecasted to reach -1.56 in one year’s time.
Technical Analysis of Rocket Pharmaceuticals Inc (RCKT)
The latest stats from [Rocket Pharmaceuticals Inc, RCKT] show that its last 5-days average volume of 1.96 million was inferior to 3.27 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 29.76%.
During the past 100 days, Rocket Pharmaceuticals Inc’s (RCKT) raw stochastic average was set at 42.37%, which indicates a significant decrease from 78.18% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.20 in the past 14 days, which was lower than the 0.21 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.44, while its 200-day Moving Average is $4.23. Now, the first resistance to watch is $3.67. This is followed by the second major resistance level at $3.81. The third major resistance level sits at $4.03. If the price goes on to break the first support level at $3.32, it is likely to go to the next support level at $3.10. The third support level lies at $2.96 if the price breaches the second support level.
Rocket Pharmaceuticals Inc (NASDAQ: RCKT) Key Stats
The company with the Market Capitalisation of 382.03 million has total of 108,222K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -258,750 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -50,330 K.
